Prevention of vertical transmission of HIV-1 in resource-limited settingsDiagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomesToxoplasma histone acetylation remodelers as novel drug targetsDengue fever: diagnosis and treatmentPathogenesis and management of Kawasaki diseaseAcute hepatitis C: prevention and treatmentTopical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspectiveCurrent and future trends in the prevention, treatment and control of rabiesResistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsRole of the gut microbiota in defining human healthEpidemiology and control of human gastrointestinal parasites in childrenThe wonder world of microbial virusesClostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistanceCurrent management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosisCircumsporozoite protein as a potential target for antimalarialsFc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseasesBacillithiol: a key protective thiol in Staphylococcus aureusClostridium difficile infection: molecular pathogenesis and novel therapeuticsStrategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosisDelivery of host cell-directed therapeutics for intracellular pathogen clearanceMannose-binding lectin and the balance between immune protection and complicationPhotodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infectionAntimicrobial stewardship: the aspirin of the 21st centuryManagement of melioidosisTherapeutic strategies for human microsporidia infectionsTreatment of anaerobic infectionA clear and present danger: tick-borne diseases in EuropeNitazoxanide: a new broad spectrum antiparasitic agentEmerging infectious diseases: vulnerabilities, contributing factors and approachesEvidence-based guidelines for the management of Lyme diseaseOptimal duration of the antimicrobial treatment of ventilator-acquired pneumoniaUse of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.Hantavirus protein interactions regulate cellular functions and signaling responses.One step closer to universal influenza epitopes.Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.Selective decontamination of the digestive tract and oropharynx: new findings for an old approach still under discussion.A designer drug against influenza: the NA inhibitor oseltamivir (Tamiflu).The role of lopinavir/ritonavir (Kaletra) in the management of HIV infected adults.Control of influenza virus infection by immunity to conserved viral features.
P1433
Q22241479-EB7ABF8F-4F3A-483E-90EF-F3942E6EBC87Q22241488-D187A076-7C31-44C7-A983-C4B60EB868DBQ22305929-F4AAAD24-7AFE-4B92-968F-1D118AB5DAC9Q22305931-D500C7DB-323B-49B5-86BC-7E633DA70A3FQ22305932-D3D9804E-AE9E-43F2-A57D-32C4FB9900C1Q22305933-B3A56F22-CAA8-416F-9AAE-4161E2B53DE1Q22305934-8FA5463E-0D08-4826-8A2C-178EEDDA8273Q22305939-3678C7B5-896F-4C0F-A613-256DEED0C778Q22305940-EC28D42E-1882-4824-A777-D79030EDB8C1Q22305941-5A227471-A3CD-4AFA-8D77-11798935D511Q24599062-41FE4AEB-1624-4EA0-88CD-641BE7F8593DQ24601973-F1C9706A-EEE4-4E06-9CB7-CE4DF35ABB70Q24625615-F627737C-999F-4B68-9467-530693D51C4EQ24632641-D4B9FCE2-8C9E-4A39-B4DC-3B0E4BE8903BQ24658293-8E0119A1-8BD9-491E-B1DA-FABD6EE768D5Q26314437-80CC8682-D06C-4441-9AAF-41FC3AB4567AQ26783175-ABCBEE84-98C7-493C-BF25-1BE81AB78192Q26799816-9CF0B8AB-E83F-4ACB-835F-E7426DE1FFA3Q26864237-BE2178F4-F827-4E2B-A66D-DAAFDB452839Q27003186-209D5D83-E7F7-4A4A-9BB6-F96DC627358DQ27006858-FD2B9F54-D1FC-4D03-A203-783A805931FEQ27011373-02E23A68-3C8E-435F-936D-E5F40D1D5C21Q27027616-5DFBE4A6-6B13-4A54-9B49-F23EAA6F9700Q28221906-8DC60271-E5BF-494A-8097-C3A385DB8BBDQ28245689-0854D550-258F-440C-AB4B-D233811B7F56Q28256376-501DA15D-1641-402B-9B25-8AC4BED04C2FQ28258687-AF4ADDA8-EC4D-4330-890A-F331209AEB68Q28267851-CD6D5099-56B1-469F-A3C8-605AF45C2761Q28287647-085988B1-1B62-4CD4-9093-A85980F4585EQ28287659-D51209C9-529D-46BE-B9F7-2CCFC4705F2AQ28296767-C3C9F833-F802-45A7-AC28-EF6382FEDA59Q28302720-D0CBEE8E-9E4A-4AF2-B77D-907ACDAA268BQ30145641-25A9D320-C8C1-417A-AACB-8AAE4DFFFD84Q30226803-CA884B51-1DF6-4F9F-B120-3C1251AB2953Q30227646-D0A61725-9184-47B8-B504-F8939DCC8E13Q30275673-52EADC79-8EE7-43FE-A4F5-9DE59D53039EQ30319118-84179917-9C31-4AF7-9C28-D7CC90B4E08DQ30343900-96EF9247-F966-4906-A102-9FB2F8F7D789Q30343901-567AB3ED-339E-4BF2-A737-5440CCFFE57BQ30343902-4E9BE328-06BA-4B0F-A6CE-613C71C1280E
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Informa
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Expert Review of Anti-Infective Therapy
@de
Expert Review of Anti-infective Therapy
@ast
Expert Review of Anti-infective Therapy
@en
Expert Review of Anti-infective Therapy
@es
Expert Review of Anti-infective Therapy
@it
Expert Review of Anti-infective Therapy
@nl
type
label
Expert Review of Anti-Infective Therapy
@de
Expert Review of Anti-infective Therapy
@ast
Expert Review of Anti-infective Therapy
@en
Expert Review of Anti-infective Therapy
@es
Expert Review of Anti-infective Therapy
@it
Expert Review of Anti-infective Therapy
@nl
prefLabel
Expert Review of Anti-Infective Therapy
@de
Expert Review of Anti-infective Therapy
@ast
Expert Review of Anti-infective Therapy
@en
Expert Review of Anti-infective Therapy
@es
Expert Review of Anti-infective Therapy
@it
Expert Review of Anti-infective Therapy
@nl
P3181
P4616
P1055
P1058
P1156
P1159
P1160
Expert Rev. Anti Infect. Ther.
P123
P1277
P1476
Expert Review of Anti-infective Therapy
@en
P236
P3181
P407
P571
2003-01-01T00:00:00Z